Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

March 09, 2023 at 07:53 AM EST

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Symbol	Price	Change (%)
AMZN	229.16	-0.51 (-0.22%)
AAPL	277.55	+0.58 (0.21%)
AMD	214.24	+8.11 (3.93%)
BAC	52.99	+0.51 (0.97%)
GOOG	320.28	-3.36 (-1.04%)
META	633.61	-2.61 (-0.41%)
MSFT	485.50	+8.51 (1.78%)
NVDA	180.26	+2.44 (1.37%)
ORCL	204.96	+7.93 (4.02%)
TSLA	426.58	+7.18 (1.71%)

Symbol

Price

Change (%)

AMZN

229.16

-0.51 (-0.22%)

AAPL

277.55

+0.58 (0.21%)

AMD

214.24

+8.11 (3.93%)

BAC

52.99

+0.51 (0.97%)

GOOG

320.28

-3.36 (-1.04%)

Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

Contact Details

More News

Recent Quotes